You are here: Industry Insights > Vista

News List

Hummingbird Bioscience Announces Trials in Progress Poster Presentation at the Society for Immunotherapy of Cancer 2021 36th Annual Meeting prnasia
November 11, 2021
Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announced a Trials in Progress...
Samsung Biologics, Kineta Enter Development and Manufacturing Agreement contractpharma
July 21, 2021
Samsung's San Francisco R&D center and South Korea headquarters to offer end-to-end CDMO service for anti-VISTA antibody immunotherapy.
Hummingbird Bioscience and MD Anderson Announce Strategic Research Collaboration To Advance Innovative Immunotherapies prnasia
July 12, 2021
Hummingbird Bioscience and The University of Texas MD Anderson Cancer Center today announced the launch of a multi-year strategic research collaboration to investigate and evaluate HMBD-002, Hummingbird's VISTA antagonist antibody.
Hummingbird Bioscience to Speak at 2021 Virtual Symposium: "VISTA: A New Immune Checkpoint in Cancer, Autoimmunity and Beyond" prnasia
June 15, 2021
Hummingbird today announced that its Chief Scientific Officer and co-founder, Dr Jerome Boyd-Kirkup, will be speaking at the 2021 virtual symposium "VISTA: A New Immune Checkpoint in Cancer, Autoimmunity and Beyond", taking place on June 18, 2021.
Hummingbird Bioscience Announces Publication of Abstract on Anti-VISTA Antibody HMBD-002 at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting prnasia
May 31, 2021
Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets today announced that its abstract reporting pre-clinical results from its V-domain immunoglobulin suppressor ...
Pierre Fabre Initiates Trial for Monoclonal Antibody Targeting VISTA Checkpoint in Solid Tumors americanpharmaceuticalreview
November 18, 2020
Pierre Fabre announced the initiation of an international Phase I clinical study in patients with relapsed or refractory solid tumors for its investigational product W0180, a monoclonal antibody targeting VISTA, developed by ...
VISTA Eye Specialist Going Digital to Raise Awareness on Preventable Blindness prnasia
April 13, 2020
Amidst the global effort to stem the spread of the COVID-19 virus, including Malaysia adopting its own Movement Control Order (MCO), VISTA Eye Specialist is not holding back their effort in its "War against Blindness" campaign.
A Powerful Catalyst On The Horizon Dr. Tran
November 26, 2018
“Looking out for mispriced betting opportunities and betting heavily when the odds are overwhelmingly in your favor is the ticket to wealth.” - Mohnish Pabrai
Vista to provide high-end health care services biospectrumasia.
August 17, 2017
Vista operates the VTO member community collectively to build an ecosystem surrounding the idea of the pan-health industry.